Advertisement
Screener

CENCORA, INC. (COR) Impairment of Long-Lived Assets to be Disposed of

2.6 / 5 stars · 59/115 Roast Me

CENCORA, INC. Impairment of Long-Lived Assets to be Disposed of

CENCORA, INC. (COR) reported Impairment of Long-Lived Assets to be Disposed of of $11.32 million for the 12-month period ending 2021-09-30, per its 10-K filed 2021-11-23.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2021-11-23

  • CENCORA, INC. impairment of long-lived assets to be disposed of for the quarter ending 2020-09-30 was $0.00.
  • CENCORA, INC. impairment of long-lived assets to be disposed of for the quarter ending 2020-06-30 was $0.00.
  • CENCORA, INC. impairment of long-lived assets to be disposed of for the quarter ending 2020-03-31 was $223.70M, a 60.75% decline year-over-year.
  • CENCORA, INC. impairment of long-lived assets to be disposed of for the quarter ending 2019-12-31 was $138.00M.
  • CENCORA, INC. impairment of long-lived assets to be disposed of for fiscal 2021 was $11.32M, a 96.87% decline from fiscal 2020.
  • CENCORA, INC. impairment of long-lived assets to be disposed of for fiscal 2020 was $361.65M, a 36.55% decline from fiscal 2019.
  • CENCORA, INC. impairment of long-lived assets to be disposed of for fiscal 2019 was $570.00M.
  • CENCORA, INC. impairment of long-lived assets to be disposed of for fiscal 2018 was $0.00.
Period endImpairment of Long-Lived Assets to be Disposed of 3 monthImpairment of Long-Lived Assets to be Disposed of 3 month as first filedImpairment of Long-Lived Assets to be Disposed of 6 monthImpairment of Long-Lived Assets to be Disposed of 9 monthImpairment of Long-Lived Assets to be Disposed of 12 month
2021-09-30$11.32M
10-K · filed 2021-11-23
2020-09-30$0.00
10-K · filed 2020-11-19
$0.00
derived: sum of 2 quarters · filed 2020-11-19
$223.70M
derived: sum of 3 quarters · filed 2021-11-23
$361.65M
10-K · filed 2021-11-23
2020-06-30$0.00
10-K · filed 2020-11-19
$223.70M
derived: sum of 2 quarters · filed 2021-11-23
$361.70M
derived: sum of 3 quarters · filed 2021-11-23
$361.70M
derived: sum of 4 quarters · filed 2021-11-23
2020-03-31$223.70M
10-K · filed 2021-11-23
$223.65M
10-K · filed 2020-11-19
$361.70M
derived: sum of 2 quarters · filed 2021-11-23
$361.70M
derived: sum of 3 quarters · filed 2021-11-23
$361.70M
derived: sum of 4 quarters · filed 2021-11-23
2019-12-31$138.00M
10-K · filed 2021-11-23
$138.00M
derived: sum of 2 quarters · filed 2021-11-23
$138.00M
derived: sum of 3 quarters · filed 2021-11-23
$708.00M
derived: sum of 4 quarters · filed 2021-11-23
2019-09-30$0.00
10-K · filed 2020-11-19
$0.00
derived: sum of 2 quarters · filed 2020-11-19
$570.00M
derived: sum of 3 quarters · filed 2021-11-23
$570.00M
10-K · filed 2021-11-23
2019-06-30$0.00
10-K · filed 2020-11-19
$570.00M
derived: sum of 2 quarters · filed 2021-11-23
$570.00M
derived: sum of 3 quarters · filed 2021-11-23
2019-03-31$570.00M
10-K · filed 2021-11-23
$570.00M
derived: sum of 2 quarters · filed 2021-11-23
2018-12-31$0.00
10-K · filed 2020-11-19
2018-09-30$0.00
10-K · filed 2020-11-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
MCKESSON CORP (MCK)United States$101.317B19.78
HERBALIFE LTD. (HLF)$1.281B8.39
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B